Works matching AU Mateos, Maria ‐ Victoria

Results: 224

Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials.

Published in:

2018

By:

Mateos, Maria‐Victoria;
Goldschmidt, Hartmut;
San‐Miguel, Jesus;
Mikhael, Joseph;
DeCosta, Lucy;
Zhou, Lifen;
Obreja, Mihaela;
Blaedel, Julie;
Szabo, Zsolt;
Leleu, Xavier;
Mateos, Maria-Victoria;
San-Miguel, Jesus

Publication type:

journal article

Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible.

Published in:

EJHaem, 2020, v. 1, n. 2, p. 481, doi. 10.1002/jha2.77

By:

Sonneveld, Pieter;
Mateos, María‐Victoria;
Alegre, Adrian;
Facon, Thierry;
Hulin, Cyrille;
Hashim, Mahmoud;
Vincken, Talitha;
Kampfenkel, Tobias;
Cote, Sarah;
He, Jianming;
Lam, Annette;
Moreau, Philippe

Publication type:

Article

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.

Published in:

Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303

By:

Caers, Jo;
Fernández de Larrea, Carlos;
Leleu, Xavier;
Heusschen, Roy;
Zojer, Niklas;
Decaux, Olivier;
Kastritis, Efstathios;
Minnema, Monique;
Jurczyszyn, Artur;
Beguin, Yves;
Wäsch, Ralph;
Palumbo, Antonio;
Dimopoulos, Meletios;
Mateos, Maria Victoria;
Ludwig, Heinz;
Engelhardt, Monika

Publication type:

Article

Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.

Published in:

Emerging Microbes & Infections, 2022, v. 11, n. 1, p. 1833, doi. 10.1080/22221751.2022.2098059

By:

Sánchez Barrueco, Álvaro;
Mateos-Moreno, María Victoria;
Martínez-Beneyto, Yolanda;
García-Vázquez, Elisa;
Campos González, Alfonso;
Zapardiel Ferrero, Javier;
Bogoya Castaño, Abel;
Alcalá Rueda, Ignacio;
Villacampa Aubá, José Miguel;
Cenjor Español, Carlos;
Moreno-Parrado, Laura;
Ausina-Márquez, Verónica;
García-Esteban, Sandra;
Artacho, Alejandro;
López-Labrador, F. Xavier;
Mira, Alex;
Ferrer, María D.

Publication type:

Article

Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.

Published in:

European Journal of Haematology, 2011, v. 86, n. 5, p. 372, doi. 10.1111/j.1600-0609.2011.01599.x

By:

Delforge, Michel;
Terpos, Evangelos;
Richardson, Paul G.;
Shpilberg, Ofer;
Khuageva, Nuriet K.;
Schlag, Rudolf;
Dimopoulos, Meletios A.;
Kropff, Martin;
Spicka, Ivan;
Petrucci, Maria T.;
Samoilova, Olga S.;
Mateos, Maria-Victoria;
Magen-Nativ, Hila;
Goldschmidt, Hartmut;
Esseltine, Dixie-Lee;
Ricci, Deborah S.;
Liu, Kevin;
Deraedt, William;
Cakana, Andrew;
van de Velde, Helgi

Publication type:

Article

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.

Published in:

European Journal of Haematology, 2011, v. 86, n. 1, p. 23, doi. 10.1111/j.1600-0609.2010.01533.x

By:

Dimopoulos, Meletios A.;
Mateos, Maria-Victoria;
Richardson, Paul G.;
Schlag, Rudolf;
Khuageva, Nuriet K.;
Shpilberg, Ofer;
Kropff, Martin;
Spicka, Ivan;
Palumbo, Antonio;
Wu, Ka Lung;
Esseltine, Dixie-Lee;
Liu, Kevin;
Deraedt, William;
Cakana, Andrew;
Van De Velde, Helgi;
San Miguel, Jesús F.

Publication type:

Article

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL–TAMO Study Group.

Published in:

European Journal of Haematology, 2008, v. 80, n. 3, p. 227, doi. 10.1111/j.1600-0609.2007.01020.x

By:

Arranz, Reyes;
Conde, Eulogio;
Grande, Carlos;
Mateos, Maria Victoria;
Gandarillas, Marco;
Albo, Carmen;
Lahuerta, Juan J.;
Fernández-Rañada, José M.;
Hernández, Miguel T.;
Alonso, Natalia;
García Vela, José A.;
Garzón, Sebastián;
Rodríguez, José;
Caballero, Dolores

Publication type:

Article

Medium-term results of percutaneous vertebroplasty in multiple myeloma.

Published in:

European Journal of Haematology, 2006, v. 77, n. 1, p. 7, doi. 10.1111/j.0902-4441.2005.t01-1-EJH2355.x

By:

Ramos, Luis;
de las Heras, José Antonio;
Sánchez, Sergio;
González-Porras, José Ramón;
González, Rafael;
Mateos, Maria Victoria;
San Miguel, Jesús F.

Publication type:

Article

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y

By:

López-Iglesias, Ana-Alicia;
Herrero, Ana B.;
Chesi, Marta;
San-Segundo, Laura;
González-Méndez, Lorena;
Hernández-García, Susana;
Misiewicz-Krzeminska, Irena;
Quwaider, Dalia;
Martín-Sánchez, Montserrat;
Primo, Daniel;
Paíno, Teresa;
Bergsagel, P. Leif;
Mehrling, Thomas;
González-Díaz, Marcos;
San-Miguel, Jesús F.;
Mateos, María-Victoria;
Gutiérrez, Norma C.;
Garayoa, Mercedes;
Ocio, Enrique M.

Publication type:

Article

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0461-8

By:

Quwaider, Dalia;
Corchete, Luis A.;
Misiewicz-Krzeminska, Irena;
Sarasquete, María E.;
Pérez, José J.;
Krzeminsk, Patryk;
Puig, Noemí;
Mateos, María Victoria;
García-Sanz, Ramón;
Herrero, Ana B.;
Gutiérrez, Norma C.

Publication type:

Article

Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.

Published in:

Advances in Therapy, 2024, v. 41, n. 2, p. 696, doi. 10.1007/s12325-023-02738-0

By:

Moreau, Philippe;
Mateos, María-Victoria;
Gonzalez Garcia, Maria Esther;
Einsele, Hermann;
De Stefano, Valerio;
Karlin, Lionel;
Lindsey-Hill, Joanne;
Besemer, Britta;
Vincent, Laure;
Kirkpatrick, Suriya;
Delforge, Michel;
Perrot, Aurore;
van de Donk, Niels W. C. J.;
Pawlyn, Charlotte;
Manier, Salomon;
Leleu, Xavier;
Martinez-Lopez, Joaquin;
Ghilotti, Francesca;
Diels, Joris;
Morano, Raúl

Publication type:

Article

Correction to: Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.

Published in:

2022

By:

Facon, Thierry;
San-Miguel, Jesús;
Dimopoulos, Meletios A.;
Mateos, Maria-Victoria;
Cavo, Michele;
van Beekhuizen, Sophie;
Yuan, Zijiao;
Mendes, João;
Lam, Annette;
He, Jianming;
Ammann, Eric;
Kumar, Shaji

Publication type:

corrected article

Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.

Published in:

Advances in Therapy, 2022, v. 39, n. 5, p. 1976, doi. 10.1007/s12325-022-02083-8

By:

Facon, Thierry;
San-Miguel, Jesús;
Dimopoulos, Meletios A.;
Mateos, Maria-Victoria;
Cavo, Michele;
van Beekhuizen, Sophie;
Yuan, Zijiao;
Mendes, João;
Lam, Annette;
He, Jianming;
Ammann, Eric;
Kumar, Shaji

Publication type:

Article

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis.

Published in:

Advances in Therapy, 2020, v. 37, n. 12, p. 4996, doi. 10.1007/s12325-020-01521-9

By:

Hungria, Vania;
Martínez-Baños, Deborah M.;
Mateos, María-Victoria;
Dimopoulos, Meletios A.;
Cavo, Michele;
Heeg, Bart;
Garcia, Andrea;
Lam, Annette;
Machnicki, Gerardo;
He, Jianming;
Fernandez, Mariana

Publication type:

Article

Delivery of Health Care by Spanish Dental Hygienists in Private and Public Dental Services during the COVID-19 De-Escalation Phase (June 2020): A Cross-Sectional Study.

Published in:

International Journal of Environmental Research & Public Health, 2021, v. 18, n. 16, p. 8298, doi. 10.3390/ijerph18168298

By:

Expósito-Delgado, Antonio Javier;
Ausina-Márquez, Verónica;
Mateos-Moreno, María Victoria;
Martínez-Sanz, Elena;
del Carmen Trullols-Casas, María;
Llamas-Ortuño, María Eulalia;
Blanco-González, José María;
Almerich-Torres, Teresa;
Bravo, Manuel;
Martínez-Beneyto, Yolanda

Publication type:

Article

Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors.

Published in:

American Journal of Hematology, 2022, v. 97, n. 7, p. 877, doi. 10.1002/ajh.26566

By:

Gozzetti, Alessandro;
Guarnieri, Andrea;
Zamagni, Elena;
Zakharova, Elena;
Coriu, Daniel;
Bittrich, Max;
Pika, Tomáš;
Tovar, Natalia;
Schutz, Natalia;
Ciofini, Sara;
Peña, Camila;
Rocchi, Serena;
Rassner, Michael;
Avivi, Irit;
Waszczuk‐Gajda, Anna;
Chhabra, Saurabh;
Usnarska‐Zubkiewicz, Lidia;
González‐Calle, Verónica;
Mateos, Maria‐Victoria;
Bocchia, Monica

Publication type:

Article

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.

Published in:

American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507

By:

Rojas, Elizabeta A.;
Corchete, Luis A.;
De Ramón, Cristina;
Krzeminski, Patryk;
Quwaider, Dalia;
García‐Sanz, Ramón;
Martínez‐López, Joaquín;
Oriol, Albert;
Rosiñol, Laura;
Bladé, Joan;
Lahuerta, Juan José;
San Miguel, Jesús F.;
González, Marcos;
Mateos, María Victoria;
Bourdon, Jean‐Christophe;
Misiewicz‐Krzeminska, Irena;
Gutiérrez, Norma C.

Publication type:

Article

Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial.

Published in:

American Journal of Hematology, 2022, v. 97, n. 4, p. 481, doi. 10.1002/ajh.26480

By:

Terpos, Evangelos;
Dimopoulos, Meletios A.;
Boccadoro, Mario;
Delimpasi, Sosana;
Beksac, Meral;
Katodritou, Eirini;
Moreau, Philippe;
Pompa, Alessandra;
Symeonidis, Argiris;
Bila, Jelena;
Oriol, Albert;
Mateos, Maria‐Victoria;
Einsele, Hermann;
Orfanidis, Ioannis;
Gries, Katharine S.;
Fastenau, John;
Liu, Kevin;
He, Jianming;
Kampfenkel, Tobias;
Qiu, Yanping

Publication type:

Article

Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

Published in:

American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434

By:

Delimpasi, Sosana;
Mateos, Maria Victoria;
Auner, Holger W.;
Gavriatopoulou, Maria;
Dimopoulos, Meletios A.;
Quach, Hang;
Pylypenko, Halyna;
Hájek, Roman;
Leleu, Xavier;
Dolai, Tuphan Kanti;
Sinha, Dinesh Kumar;
Venner, Christopher P.;
Benjamin, Reuben;
Garg, Mamta Krishnan;
Doronin, Vadim;
Levy, Yair;
Moreau, Philippe;
Chai, Yi;
Arazy, Melina;
Shah, Jatin

Publication type:

Article

Covid‐19 vaccination in patients with multiple myeloma: Focus on immune response.

Published in:

American Journal of Hematology, 2021, v. 96, n. 8, p. 896, doi. 10.1002/ajh.26263

By:

Ludwig, Heinz;
San‐Miguel, Jesús;
Munshi, Nikhil;
Sonneveld, Pieter;
Mateos, María‐Victoria;
Moreau, Philippe;
Terpos, Evangelos

Publication type:

Article

Authors' Response.

Published in:

American Journal of Hematology, 2015, v. 90, n. 8, p. 146, doi. 10.1002/ajh.24079

By:

Mateos, María-Victoria;
Shi, Hongliang;
San Miguel, Jesús F.

Publication type:

Article

Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.

Published in:

American Journal of Hematology, 2015, v. 90, n. 4, p. 314, doi. 10.1002/ajh.23933

By:

Mateos, María Victoria;
Richardson, Paul G.;
Dimopoulos, Meletios A.;
Palumbo, Antonio;
Anderson, Kenneth C.;
Shi, Hongliang;
Elliott, Jennifer;
Dow, Edward;
van de Velde, Helgi;
Niculescu, Liviu;
San Miguel, Jesús F.

Publication type:

Article

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

Published in:

American Journal of Hematology, 2014, v. 89, n. 4, p. 355, doi. 10.1002/ajh.23641

By:

Morabito, Fortunato;
Bringhen, Sara;
Larocca, Alessandra;
Wijermans, Pierre;
Victoria Mateos, Maria;
Gimsing, Peter;
Mazzone, Carla;
Gottardi, Daniela;
Omedè, Paola;
Zweegman, Sonja;
José Lahuerta, Juan;
Zambello, Renato;
Musto, Pellegrino;
Magarotto, Valeria;
Schaafsma, Martijn;
Oriol, Albert;
Juliusson, Gunnar;
Cerrato, Chiara;
Catalano, Lucio;
Gentile, Massimo

Publication type:

Article

Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.

Published in:

Biomedicines, 2024, v. 12, n. 6, p. 1153, doi. 10.3390/biomedicines12061153

By:

Agulló, Cristina;
Puig, Noemí;
Contreras, Teresa;
Castro, Sergio;
Puertas, Borja;
González-Calle, Verónica;
Rey-Búa, Beatriz;
Mateos, María Victoria

Publication type:

Article

Once‐weekly (70 mg/m<sup>2</sup>) vs twice‐weekly (56 mg/m<sup>2</sup>) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION‐1 trials.

Published in:

Cancer Medicine, 2020, v. 9, n. 9, p. 2989, doi. 10.1002/cam4.2945

By:

Moreau, Philippe;
Stewart, Keith A.;
Dimopoulos, Meletios;
Siegel, David;
Facon, Thierry;
Berenson, James;
Raje, Noopur;
Berdeja, Jesus G.;
Orlowski, Robert Z.;
Yang, Hui;
Ma, Haijun;
Klippel, Zandra;
Zahlten‐Kumeli, Anita;
Mezzi, Khalid;
Iskander, Karim;
Mateos, Maria‐Victoria

Publication type:

Article

Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01170-z

By:

Rajkumar, S. Vincent;
Mateos, María-Victoria;
Schaeffer, Marcy;
Lin, Xiwu;
Bathija, Sacheeta;
Gupta-Werner, Niodita;
Lam, Annette;
Carson, Robin;
Dennis, Robyn;
Kaila, Shuchita;
Matt, Kathryn;
Duran, Joana;
Lonial, Sagar

Publication type:

Article

Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01160-1

By:

van de Donk, Niels W. C. J.;
Bahlis, Nizar;
Costa, Luciano J.;
Mateos, María-Victoria;
Nooka, Ajay K.;
Perrot, Aurore;
Garfall, Alfred L.;
Thaman, Pragya;
Qi, Keqin;
Uhlar, Clarissa;
Chastain, Katherine;
Doyle, Margaret;
Usmani, Saad Z.

Publication type:

Article

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01109-4

By:

Pawlyn, Charlotte;
Schjesvold, Fredrik H.;
Cairns, David A.;
Wei, L. J.;
Davies, Faith;
Nadeem, Omar;
Abdulhaq, Haifaa;
Mateos, Maria-Victoria;
Laubach, Jacob;
Weisel, Katja;
Ludwig, Heinz;
Rajkumar, S. Vincent;
Sonneveld, Pieter;
Jackson, Graham;
Morgan, Gareth;
Richardson, Paul G.

Publication type:

Article

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00879-7

By:

Raje, Noopur;
Anderson, Kenneth;
Einsele, Hermann;
Efebera, Yvonne;
Gay, Francesca;
Hammond, Sarah P.;
Lesokhin, Alexander M.;
Lonial, Sagar;
Ludwig, Heinz;
Moreau, Philippe;
Patel, Krina;
Ramasamy, Karthik;
Mateos, Maria-Victoria

Publication type:

Article

Global disparities in patients with multiple myeloma: a rapid evidence assessment.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00877-9

By:

Mateos, Maria-Victoria;
Ailawadhi, Sikander;
Costa, Luciano J.;
Grant, Shakira J.;
Kumar, Lalit;
Mohty, Mohamad;
Aydin, Didem;
Usmani, Saad Z.

Publication type:

Article

Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00866-y

By:

Raje, Noopur;
Mateos, María-Victoria;
Iida, Shinsuke;
Reece, Donna

Publication type:

Article

Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00804-y

By:

Raje, Noopur;
Mateos, María-Victoria;
Iida, Shinsuke;
Reece, Donna

Publication type:

Article

Multiple myeloma with t(11;14): impact of novel agents on outcome.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00807-9

By:

Puertas, Borja;
González-Calle, Verónica;
Sobejano-Fuertes, Eduardo;
Escalante, Fernando;
Rey-Bua, Beatriz;
Padilla, Irene;
García-Sanz, Ramón;
Puig, Noemi;
Gutiérrez, Norma C.;
Mateos, María-Victoria

Publication type:

Article

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x

By:

Moreau, Philippe;
Chari, Ajai;
Oriol, Albert;
Martinez-Lopez, Joaquin;
Haenel, Mathias;
Touzeau, Cyrille;
Ailawadhi, Sikander;
Besemer, Britta;
de la Rubia Comos, Javier;
Encinas, Cristina;
Mateos, Maria-Victoria;
Salwender, Hans;
Rodriguez-Otero, Paula;
Hulin, Cyrille;
Karlin, Lionel;
Sureda Balari, Anna;
Bargay, Joan;
Benboubker, Lotfi;
Rosiñol, Laura;
Tarantolo, Stefano

Publication type:

Article

Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00804-y

By:

Raje, Noopur;
Mateos, María-Victoria;
Iida, Shinsuke;
Reece, Donna

Publication type:

Article

Multiple myeloma with t(11;14): impact of novel agents on outcome.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00807-9

By:

Puertas, Borja;
González-Calle, Verónica;
Sobejano-Fuertes, Eduardo;
Escalante, Fernando;
Rey-Bua, Beatriz;
Padilla, Irene;
García-Sanz, Ramón;
Puig, Noemi;
Gutiérrez, Norma C.;
Mateos, María-Victoria

Publication type:

Article

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Published in:

2023

By:

Moreau, Philippe;
Chari, Ajai;
Oriol, Albert;
Martinez-Lopez, Joaquin;
Haenel, Mathias;
Touzeau, Cyrille;
Ailawadhi, Sikander;
Besemer, Britta;
de la Rubia Comos, Javier;
Encinas, Cristina;
Mateos, Maria-Victoria;
Salwender, Hans;
Rodriguez-Otero, Paula;
Hulin, Cyrille;
Karlin, Lionel;
Sureda Balari, Anna;
Bargay, Joan;
Benboubker, Lotfi;
Rosiñol, Laura;
Tarantolo, Stefano

Publication type:

Letter

Smoldering multiple myeloma current treatment algorithms.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00719-0

By:

Rajkumar, S. Vincent;
Kumar, Shaji;
Lonial, Sagar;
Mateos, Maria Victoria

Publication type:

Article

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00629-1

By:

Cohen, Adam D.;
Parekh, Samir;
Santomasso, Bianca D.;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W. C. J.;
Arnulf, Bertrand;
Mateos, Maria-Victoria;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
De Braganca, Kevin C.;
Schecter, Jordan M.;
Marquez, Loreta;
Lee, Erin;
Cornax, Ingrid;
Zudaire, Enrique;
Li, Claire;
Olyslager, Yunsi;
Madduri, Deepu;
Varsos, Helen;
Pacaud, Lida

Publication type:

Article

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4

By:

Terpos, Evangelos;
Mikhael, Joseph;
Hajek, Roman;
Chari, Ajai;
Zweegman, Sonja;
Lee, Hans C.;
Mateos, María-Victoria;
Larocca, Alessandra;
Ramasamy, Karthik;
Kaiser, Martin;
Cook, Gordon;
Weisel, Katja C.;
Costello, Caitlin L.;
Elliott, Jennifer;
Palumbo, Antonio;
Usmani, Saad Z.

Publication type:

Article

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.

Published in:

Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00372-5

By:

Martínez-López, Joaquín;
Mateos, María-Victoria;
Encinas, Cristina;
Sureda, Anna;
Hernández-Rivas, José Ángel;
Lopez de la Guía, Ana;
Conde, Diego;
Krsnik, Isabel;
Prieto, Elena;
Riaza Grau, Rosalía;
Gironella, Mercedes;
Blanchard, María Jesús;
Caminos, Nerea;
Fernández de Larrea, Carlos;
Senin, María Alicia;
Escalante, Fernando;
de la Puerta, José Enrique;
Giménez, Eugenio;
Martínez-Barranco, Pilar;
Mateos, Juan José

Publication type:

Article

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.

Published in:

Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4

By:

Dimopoulos, Meletios A.;
Lonial, Sagar;
White, Darrell;
Moreau, Philippe;
Weisel, Katja;
San-Miguel, Jesus;
Shpilberg, Ofer;
Grosicki, Sebastian;
Špička, Ivan;
Walter-Croneck, Adam;
Magen, Hila;
Mateos, Maria-Victoria;
Belch, Andrew;
Reece, Donna;
Beksac, Meral;
Spencer, Andrew;
Oakervee, Heather;
Orlowski, Robert Z.;
Taniwaki, Masafumi;
Röllig, Christoph

Publication type:

Article

Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis.

Published in:

Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0300-y

By:

Dimopoulos, Meletios A.;
Niesvizky, Ruben;
Weisel, Katja;
Siegel, David S.;
Hajek, Roman;
Mateos, María-Victoria;
Cavo, Michele;
Huang, Mei;
Zahlten-Kumeli, Anita;
Moreau, Philippe

Publication type:

Article

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.

Published in:

Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0253-1

By:

Rojas, Elizabeta A.;
Corchete, Luis A.;
Mateos, María Victoria;
García-Sanz, Ramón;
Misiewicz-Krzeminska, Irena;
Gutiérrez, Norma C.

Publication type:

Article

Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

Published in:

Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3

By:

Moreau, Philippe;
Donk, Niels;
Miguel, Jesus;
Lokhorst, Henk;
Nahi, Hareth;
Ben-Yehuda, Dina;
Cavo, Michele;
Cook, Gordon;
Delforge, Michel;
Einsele, Hermann;
Zweegman, Sonja;
Ludwig, Heinz;
Driessen, Christoph;
Palumbo, Antonio;
Facon, Thierry;
Plesner, Torben;
Dimopoulos, Meletios;
Sondergeld, Pia;
Sonneveld, Pieter;
Mateos, María-Victoria

Publication type:

Article

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

Published in:

Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4

By:

Moreau, Philippe;
Donk, Niels;
Miguel, Jesus;
Lokhorst, Henk;
Nahi, Hareth;
Ben-Yehuda, Dina;
Cavo, Michele;
Cook, Gordon;
Delforge, Michel;
Einsele, Hermann;
Zweegman, Sonja;
Ludwig, Heinz;
Driessen, Christoph;
Palumbo, Antonio;
Facon, Thierry;
Plesner, Torben;
Dimopoulos, Meletios;
Sondergeld, Pia;
Sonneveld, Pieter;
Mateos, María-Victoria

Publication type:

Article

Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 9, p. 1714, doi. 10.3109/10428194.2012.662643

By:

Alegre, Adrian;
Oriol-Rocafiguera, Albert;
Garcia-Larana, Jose;
Mateos, Maria-Victoria;
Sureda, Anna;
Martinez-Chamorro, Carmen;
Cibeira, Maria Teresa;
Aguado, Beatriz;
Knight, Robert;
Rosettani, Barbara

Publication type:

Article

Targeted therapy and maintenance in myeloma.

Published in:

British Medical Bulletin, 2017, v. 122, p. 163, doi. 10.1093/bmb/ldx013

By:

Mateos, María-Victoria;
González-Calle, Verónica

Publication type:

Article

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis.

Published in:

HemaSphere, 2024, v. 8, n. 11, p. 1, doi. 10.1002/hem3.70041

By:

Ocio, Enrique M.;
Perrot, Aurore;
Moreau, Philippe;
Mateos, Maria‐Victoria;
Bringhen, Sara;
Martínez‐López, Joaquín;
Karlin, Lionel;
Wang, Song‐Yau;
Oprea, Corina;
Li, Yi;
Kodas, Ercem;
San‐Miguel, Jesus

Publication type:

Article

Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study.

Published in:

HemaSphere, 2023, v. 7, n. 9, p. 1, doi. 10.1097/HS9.0000000000000942

By:

Ramasamy, Karthik;
Avet-Loiseau, Hervé;
Hveding Blimark, Cecilie;
Delforge, Michel;
Gay, Francesca;
Manier, Salomon;
Martinez-Lopez, Joaquín;
Mateos, Maria Victoria;
Mohty, Mohamad;
van de Donk, Niels W. C. J.;
Weisel, Katja

Publication type:

Article